AEON Biopharma, Inc. (AEON): Total Assets
$5.56M
As of 2025-12-31
$5.91M
As of 2026-06-30
-19.8%
3-year compound annual growth
n/m
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.56M | +77.0% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $3.14M | -54.1% | 2026-03-30, Balance as of period end |
| 2023-12-31 | $6.84M | -36.5% | 2025-03-24, Balance as of period end |
| 2022-12-31 | $10.78M | -96.1% | 2024-05-14, Balance as of period end |
| 2021-12-31 | $276.95M | n/m | 2023-04-10, Balance as of period end |
| 2020-12-31 | $81.0K | n/a | 2022-03-28, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| AEON Biopharma, Inc. (AEON) | 2025-12-31 | $5.56M | +77.0% |
| Jupiter Neurosciences, Inc. (JUNS) | 2025-12-31 | $5.56M | -10.3% |
| CDT Equity Inc. (CDT) | 2025-12-31 | $5.65M | +34.7% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $5.37M | -6.8% |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | $5.33M | -60.5% |
| Ernexa Therapeutics Inc. (ERNA) | 2025-12-31 | $5.83M | +10.7% |
| Polaryx Therapeutics, Inc. (PLYX) | 2025-12-31 | $5.17M | +3.4% |
| Petros Pharmaceuticals, Inc. (PTPI) | 2025-12-31 | $5.16M | -51.4% |
| Enveric Biosciences, Inc. (ENVB) | 2025-12-31 | $5.10M | +65.3% |
Compare AEON, JUNS, CDT, SXTP side by side · Screen every company in Pharmaceutical Preparations ↗